Related references
Note: Only part of the references are listed.Cancer gene therapy using mesenchymal stem cells
Ryosuke Uchibori et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2014)
Double suicide gene therapy using human neural stem cells against glioblastoma: double safety measures
Ji Yeoun Lee et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Mesenchymal stromal cells retrovirally transduced with prodrug-converting genes are suitable vehicles for cancer gene therapy
E. Durinikova et al.
ACTA VIROLOGICA (2014)
Lentivirus-mediated CD/TK fusion gene transfection neural stem cell therapy for C6 glioblastoma
Jian Niu et al.
TUMOR BIOLOGY (2013)
Tumor microenvironment and the role of mesenchymal stromal cells
L. Kucerova et al.
NEOPLASMA (2013)
Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models
N-H Kang et al.
CANCER GENE THERAPY (2012)
Neural stem cell-based dual suicide gene delivery for metastatic brain tumors
C. Wang et al.
CANCER GENE THERAPY (2012)
Selective killing of lung cancer cells using carcinoembryonic antigen promoter and double suicide genes, thymidine kinase and cytosine deaminase (pCEA-TK/CD)
Yuan Qiu et al.
CANCER LETTERS (2012)
Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells
Miroslava Matuskova et al.
JOURNAL OF GENE MEDICINE (2012)
Mesenchymal Stem Cell-Based Tumor-Targeted Gene Therapy in Gastrointestinal Cancer
Qi Bao et al.
STEM CELLS AND DEVELOPMENT (2012)
Selective Targeting of Genetically Engineered Mesenchymal Stem Cells to Tumor Stroma Microenvironments Using Tissue-Specific Suicide Gene Expression Suppresses Growth of Hepatocellular Carcinoma
Hanno Niess et al.
ANNALS OF SURGERY (2011)
Targeted killing effects of double CD and TK suicide genes controlled by survivin promoter on gastric cancer cell
Xian-Run Luo et al.
MOLECULAR BIOLOGY REPORTS (2011)
HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells
Miroslava Matuskova et al.
CANCER LETTERS (2010)
Toward Brain Tumor Gene Therapy Using Multipotent Mesenchymal Stromal Cell Vectors
Daniel Bexell et al.
MOLECULAR THERAPY (2010)
Adipose Tissue-derived Mesenchymal Stem Cells Expressing Prodrug-converting Enzyme Inhibit Human Prostate Tumor Growth
Ilaria T. Cavarretta et al.
MOLECULAR THERAPY (2010)
Synthetic isothiocyanate indole-3-ethyl isothiocyanate (homoITC) enhances sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to cisplatin
P. Stehlik et al.
NEOPLASMA (2010)
Stem and progenitor cell-mediated tumor selective gene therapy
K. S. Aboody et al.
GENE THERAPY (2008)
Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice
Lucia Kucerova et al.
JOURNAL OF GENE MEDICINE (2008)
Mesenchymal Stem Cells: An Emerging Tool for Cancer Targeting and Therapy
Vanessa Fritz et al.
CURRENT STEM CELL RESEARCH & THERAPY (2008)
Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy
Lucia Kucerova et al.
CANCER RESEARCH (2007)
A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy
PD Boucher et al.
CANCER RESEARCH (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model
S Moriuchi et al.
GENE THERAPY (2002)
Share Paper
